Ryan Whitacre (PhD, UCSF & UC Berkeley) is a postdoctoral research fellow at the Global Health Centre, where he traces emergent trends in the science and economics of global health. His current research aims to improve the role of finance in R&D and scale-up for medicines to treat and prevent antimicrobial resistance (AMR), Ebola, and HIV.
Before joining the Centre, he explored best practices to develop and implement novel biomedical technologies, including oral HIV pre-exposure prophylaxis (PrEP) and CRISPR-Cas9 gene-edited therapies, with interdisciplinary teams at UCSF, UC Berkeley, and the San Francisco Department of Public Health. Projects spanned upstream and downstream issues, including clinical trial design, regulation, access, insurance coverage, provider support, patient uptake, and retention in care. He also taught undergraduate and master’s level courses in anthropology, business, and global health sciences.
- Whitacre R, Buchbinder L, Holmes S (2020) The Pandemic Present. Social Anthropology.
- Spinelli MA, Laborde N, Kinley P, Whitacre R, Scott HM, Walker N, Liu AY, Gandhi M, Buchbinder SP (2020) Missed Opportunities to Prevent HIV Infections among Pre-Exposure Prophylaxis Users: A Population-Based Mixed Methods Study, San Francisco, United States. Journal of the International AIDS Society.
- Laborde N, Kinley P, Spinelli M, Vittinghoff E, Whitacre R, Scott HM, Buchbinder SP (2020) Understanding PrEP Persistence: Provider and Patient Perspectives. AIDS Behav.
- Whitacre R (2020) From advocacy to austerity: The new role of the U.S. public sector in HIV drug development and access, Global Public Health.
- Whitacre R (2019) A Critically Applied Approach to PrEP, Introduction to Edited Series, Somatosphere.
- Whitacre R (2018) Intimate Innovation: Political economy, subjectivity, and a novel method to prevent HIV, University of California, San Francisco, Dissertations.